Moving averages
SMA 200$0.19-99.32%
Company profile
Carisma Therapeutics, Inc., a biopharmaceutical company, develops chimeric antigen receptors (CAR) macrophages for the treatment of solid tumors. The company is headquartered in Philadelphia, Pennsylvania.
SectorHealthcare
IndustryBiotechnology
Market cap$1.55M
P/E ratio0.195
EPS$0.19
Beta3.581
Dividend yield0.00%
52-week high$1.27
52-week low$0.03
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 52
VRTX
Vertex Pharmaceuticals Inc
RSI 64
CRSP
CRISPR Therapeutics AG
RSI 54
IOVA
Iovance Biotherapeutics Inc
RSI 66
MRNA
Moderna Inc
RSI 67
VKTX
Viking Therapeutics Inc
RSI 49
SRPT
Sarepta Therapeutics Inc
RSI 67
EDIT
Editas Medicine Inc
RSI 52
NVAX
Novavax Inc
RSI 72
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 44
RSI alerts for CARM
Get an email the moment Carisma Therapeutics Inc. crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 12 March 2026 at 9:20 PM EDT